HemaSphere
(Aug 2024)
Prognostic relevance of molecular measurable residual disease detection in AML with mutated CEBPA
- Christian M. Vonk,
- Emma L. Boertjes,
- Francois G. Kavelaars,
- Melissa Rijken,
- Jolinda M. L. Konijnenburg,
- Roxanne E. Cromwell,
- Bob Löwenberg,
- Tim Grob,
- Peter J. M. Valk
Affiliations
- Christian M. Vonk
- Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands
- Emma L. Boertjes
- Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands
- Francois G. Kavelaars
- Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands
- Melissa Rijken
- Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands
- Jolinda M. L. Konijnenburg
- Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands
- Roxanne E. Cromwell
- Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands
- Bob Löwenberg
- Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands
- Tim Grob
- Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands
- Peter J. M. Valk
- Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands
- DOI
-
https://doi.org/10.1002/hem3.141
- Journal volume & issue
-
Vol. 8,
no. 8
pp.
n/a
– n/a
WeChat QR code
